Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Klinische Monatsblatter Fur Augenheilkunde
|
April 9, 2015
[Intraoperative Measurement of Refraction with a Hand-Held Autorefractometer]
C Gesser, T Küper, G Richard, et al.
Seminars in Nuclear Medicine
|
December 2, 2025
New targets of PET imaging for renal cancer
Y Katayeu, V Grünwald, K M Pabst, et al.
Theranostics
|
July 1, 2024
PSMA-PET follow-up to assess response in patients not receiving PSMA therapy: Is there value beyond localization of disease?
Alina T Küper, David Kersting, Tugce Telli, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 25, 2025
Thyroid Hormone Withdrawal Yields Higher <sup>131</sup>I Absorbed Dose to Metastases Than rhTSH Stimulation in Differentiated Thyroid Cancer: Evidence from a Large <sup>124</sup>I PET/CT Dosimetry Cohort
Ieva Čiučiulkaitė, Giulia A Zuccotti, Cherbel Jallo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 25, 2026
SSTR-Targeted Radiotheranostics in Breast Cancer: A Comparison of [<sup>68</sup>Ga]Ga-DOTATOC and [<sup>68</sup>Ga]Ga-SSO120 with [<sup>18</sup>F]FDG PET
Alina T Küper, Lalith Kumar Shiyam Sundar, Loíc Djaileb, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 25, 2025
Potential value of [<sup>68</sup>Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma: a bi-centric analysis
Kim M Pabst, Sophie C Siegmund, Adrien Holzgreve, et al.
The Lancet. Oncology
|
August 7, 2025
[<sup>68</sup>Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial
Kim M Pabst, Manuel M Weber, Christina Laschinsky, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Klinische Monatsblatter Fur Augenheilkunde
|
April 9, 2015
[Intraoperative Measurement of Refraction with a Hand-Held Autorefractometer]
C Gesser, T Küper, G Richard, et al.
Seminars in Nuclear Medicine
|
December 2, 2025
New targets of PET imaging for renal cancer
Y Katayeu, V Grünwald, K M Pabst, et al.
Theranostics
|
July 1, 2024
PSMA-PET follow-up to assess response in patients not receiving PSMA therapy: Is there value beyond localization of disease?
Alina T Küper, David Kersting, Tugce Telli, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 25, 2025
Thyroid Hormone Withdrawal Yields Higher <sup>131</sup>I Absorbed Dose to Metastases Than rhTSH Stimulation in Differentiated Thyroid Cancer: Evidence from a Large <sup>124</sup>I PET/CT Dosimetry Cohort
Ieva Čiučiulkaitė, Giulia A Zuccotti, Cherbel Jallo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 25, 2026
SSTR-Targeted Radiotheranostics in Breast Cancer: A Comparison of [<sup>68</sup>Ga]Ga-DOTATOC and [<sup>68</sup>Ga]Ga-SSO120 with [<sup>18</sup>F]FDG PET
Alina T Küper, Lalith Kumar Shiyam Sundar, Loíc Djaileb, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 25, 2025
Potential value of [<sup>68</sup>Ga]Ga-FAPI-46 PET in patients with metastatic urothelial carcinoma: a bi-centric analysis
Kim M Pabst, Sophie C Siegmund, Adrien Holzgreve, et al.
The Lancet. Oncology
|
August 7, 2025
[<sup>68</sup>Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial
Kim M Pabst, Manuel M Weber, Christina Laschinsky, et al.
Page
of 1